Twin Tree Management, LP Incyte Corp Put Options Transaction History

Twin Tree Management, LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $522,036 - $650,250	10,200 New	10,200 $618,000
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $7.49 Million - $9.82 Million	-102,600 Reduced 92.85%	7,900 $690,000
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $4.06 Million - $4.85 Million	-69,400 Reduced 38.58%	110,500 $7.03 Million
Q2 2018 Aug 08, 2018	BUY	$60.85 - $83.98 $10.9 Million - $15.1 Million	179,900 New	179,900 $12.1 Million
Q1 2018 May 09, 2018	SELL	$83.06 - $100.98 $124,590 - $151,470	-1,500 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $163,725 - $207,405	1,500	1,500 $175,000

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.